packageRelatlimab

Relatlimab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Relatlimab is a monoclonal antibody used as an anticancer agent in combination with another monoclonal antibody. It is an approved drug, though it does not appear to be authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q58315670 and the WHO ATC classification; not checked by a person.

name:Relatlimab
ATC codes:L01FY02
DrugBank:DB14851
Wikidata:Q58315670

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown